Seer inc.

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that ...Aug 14, 2023 · SEER*Stat is a statistical software that calculates raw data of cancer statistics, rates, and trends. The SEER*Stat statistical software provides a convenient, intuitive mechanism for the analysis of SEER and other cancer-related databases. It is a powerful PC tool to view individual cancer records and to produce statistics for studying …Price Performance Review of SEER. On Tuesday, Seer Inc [NASDAQ:SEER] saw its stock fall -0.60% to $1.67. On the same session, the stock had its day’s lowest price of $1.5701, but rose to a high of $1.68. Over the last five days, the stock has lost -4.57%. Seer Inc shares have fallen nearly -71.21% since the year began.Nov 7, 2023 · SEER Seer Inc Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500. REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc ...

Seer, Inc. (SEER) came out with a quarterly loss of $0.38 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.30 per share a year ago. These figures are adjusted for ...Seer’s Proteograph™ technology offers richer access to the proteome. Keep scrolling to learn how an unbiased view of the proteome can reveal biological discoveries you never thought possible. For decades, a limiting factor in proteomics research has been the inability to access the proteome in ways necessary to survey and understand its ... Seer | 7,681 followers on LinkedIn. Empowering scientists through unbiased, deep, rapid proteomics at scale | At Seer, we develop innovative solutions that act as a gateway to the proteome. Our ...

Jan 25, 2021 · REDWOOD CITY, Calif., Jan. 25, 2021 -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed...

Dec 1, 2023 · About SEER. Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will ...Pursuant to Rule 461 under the Securities Act of 1933, as amended, Seer, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-252395) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its …Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and ...

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center. Seer press releases: company announcements, financials, product and technology updates, investor events, and more.

Seer, Inc. (Exact name of registrant as specified in its charter) Delaware: 001-39747: 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer: incorporation) File Number) Identification No.) 3800 Bridge Parkway, Suite 102. Redwood City, California 94065

REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2022.Nov 8, 2023 · We are a life sciences company committed to pushing science forward every day. Our Proteograph XT technology, equipped with engineered nanoparticles and automated workflows, unveils the proteome's complexity like never before, accelerating your research and discovery journey. NASDAQ GS: SEER $1.70 Realtime driving directions to Seer Inc., 3800 Bridge Pkwy, Redwood City, based on live traffic updates and road conditions – from Waze fellow drivers.Seer, Inc. (Exact name of registrant as specified in its charter) Delaware: 001-39747: 82-1153150 (State or other jurisdiction of (Commission (I.R.S. Employer: incorporation) File Number) Identification No.) 3800 Bridge Parkway, Suite 102. Redwood City, California 94065Seer Solutions Inc. is a professionally managed Technical Consulting Company focusing on highly skilled information technology consultants, headquartered in Sterling, VA. We provide highly trained and experienced staff in specific technologies to Fortune 500 firms. Our ability to recruit and provide candidates across the countries gives us a ...

Ms. Friedman served in various executive roles from 1982 to 2006 at Morgan Stanley, an investment bank and financial services company, including as Manager Director from 1997 to 2006 and Head of West Coast Healthcare and Co-Head of the Biotechnology Practice from 1993 to 2006. She currently serves on the board of directors of Lyell Immunopharma ...THE FINANCE SEER LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, ...Seer, Inc. (SEER) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.38 per share a year ago. These figures are ...Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...The projected annualized growth rate until the end of 2024 for Seer is 17%, significantly lower than the historical growth rate of 62% per year over the past five years. In comparison, other companies in the industry are forecasted to achieve a revenue growth rate of 3.7% per year. 3. Should investors be cautious about Seer?

C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 (Street) REDWOOD CITY: CA: 94065 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Seer, Inc. [ SEER] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below)Legal Name Seer, Inc. Stock Symbol NASDAQ:SEER. Company Type For Profit. Contact Email [email protected]. Phone Number (650) 453-0000. Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular ...

Seer Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Seer Inc’s trailing 12-month revenue is $16.6 million with a -564.9% profit margin. Year-over-year quarterly sales growth most recently was 11.1%. Analysts expect adjusted earnings to reach $-1.443 per share for the current fiscal year.Legal Name Seer, Inc. Stock Symbol NASDAQ:SEER. Company Type For Profit. Contact Email [email protected]. Phone Number (650) 453-0000. Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular ...May 9, 2023 · Seer will host a conference call to discuss the first quarter 2023 financial results on Tuesday, May 9, 2023 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the conference call can be ... Jun 24, 2021 · The boardroom was abuzz, however, with news that Seer Inc. of Redwood City — also an early-stage life sciences firm — had just successfully raised money through an initial public stock offering.Strategic Environmental & Energy Resources, Inc. (SEER) is a publicly traded holding company that provides a wide range of environmental, renewable fuels and industrial waste stream management services. The Company serves a diverse customer base that includes oil and gas refineries, regional landfills, medical waste destruction operations, and food …Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across ...REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will ...We are pleased to invite you to attend the 2023 Annual Meeting of Stockholders (the Annual Meeting) of Seer, Inc. (Seer or the Company), which will take place on Wednesday, June 14, 2023 at 1:00 p.m. Pacific Time. The Annual Meeting will …

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and ...

SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control ...

Mar 2, 2023 · Seer, Inc. Grew revenue 134% and increased instruments shipped 129% year over year. REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company ... Glassdoor gives you an inside look at what it's like to work at Seer Solutions, including salaries, reviews, office photos, and more. This is the Seer Solutions company profile. All content is posted anonymously by employees working at Seer Solutions. See what employees say it's like to work at Seer Solutions.Nov 24, 2023 · Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. — Seer to retain minority ownership in PrognomIQ — Redwood City, CA, September 15, 2020 — Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced that it has spun out and completed the initial financing of $55M ...Jun 30, 2023 · Seer, Inc. UNAUDITED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts) June 30, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 56,404 $ 53,208 Short-term investments 263,805 368,031 Accounts receivable, net 4,490 4,315 Related party receivables Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company's initial product, the Proteograph Product Suite (Proteograph), is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours.Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product ...C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 (Street) REDWOOD CITY: CA: 94065 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Seer, Inc. [ SEER] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below)

Product and Service Revenue: Seer’s product revenue for the quarter reached $1.8 million, reflecting a 31% decline from $2.6 million in the third quarter of 2022. On the other hand, the company experienced an impressive growth in service revenue, which soared nearly eightfold from $68,000 in the same period last year to $536,000 in Q3 2023.Competing Interest Statement. A.W.K is a member of the Scientific Advisory Board for Nine Square Therapeutics, Inc. J.E. is an advisor to Seer, Inc. M. K. has filed a patent application related to CRISPRi and CRISPRa screening (PCT/US15/40449) and serves on the Scientific Advisory Board of Engine Biosciences, Casma Therapeutics, and …seer, inc. CONSULTANT AGREEMENT This Consultant Agreement (“Agreement”) is entered into as of September 30, 2022 (the “Effective Date”) between Seer, Inc., a Delaware corporation with its principal place of business at 3800 Bridge Parkway, Suite 102, Redwood City, CA 94065 (“Company”) and Omead Ostadan, an individual (“Consultant”).The stock of Seer Inc (SEER) has gone up by 10.06% for the week, with a -3.85% drop in the past month and a -26.47% drop in the past quarter. The volatility ratio for the week is 11.18%, and the volatility levels for the past 30 days are 7.92% for SEER. The simple moving average […]Instagram:https://instagram. best gold online dealersstocks buy ratingdiscount forex brokerwhat is the best biotech stock to buy right now Get a real-time Seer, Inc. (SEER) stock price quote with breaking news, financials, statistics, charts and more.Seer, Inc. UNAUDITED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts) June 30, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 56,404 $ 53,208 Short-term investments 263,805 368,031 Accounts receivable, net 4,490 4,315 Related party receivables silver is undervaluedtanker stocks Jun 30, 2022 · Net loss was $22.8 million for the second quarter of 2022, as compared to $16.6 million for the corresponding prior year period. Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million. [email protected]. Seer, Inc.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except share and per ... get stock Jun 7, 2023 · Follow. REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced ... 8 Okt 2021 ... Leave of Absence Agreement between Omead Ostadan and the Company effective October 7, 2021 from Seer, Inc. filed with the Securities and ...SC 13G 1 seer-13gof12x31x20214875x3.htm SC 13G UNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 ...